Related Experiment Video

Updated: Aug 8, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Apoptosis induced in mammalian cells by small peptides that functionally antagonize the Rb-regulated E2F

L R Bandara1, R Girling, N B La Thangue

  • 1Prolifix Ltd, London, UK.

Nature Biotechnology
|November 5, 1997
PubMed

Insights

Researchers targeted the E2F transcription factor, a key cell cycle regulator, with antagonistic peptides. This intervention rapidly induced apoptosis in mammalian tumor cells by inactivating E2F, suggesting a potential cancer therapy approach.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The E2F transcription factor is a critical regulator of the mammalian cell cycle.
  • Aberrant E2F pathway activity is observed in most human tumor cells.
  • Modulating E2F activity presents a potential therapeutic strategy for cancer.

Purpose of the Study:

  • To investigate the role of E2F in cell cycle regulation.
  • To evaluate the therapeutic potential of targeting E2F DNA binding activity.

Main Methods:

  • Introduction of peptides designed to antagonize E2F DNA binding into mammalian cells.
  • Observation of cellular responses, including apoptosis and E2F activity.
  • Correlation of apoptosis onset with E2F inactivation.

Main Results:

  • Introduction of E2F-antagonizing peptides into mammalian tumor cells led to rapid apoptosis.
  • The observed apoptosis correlated directly with the inactivation of physiological E2F.
  • Demonstrated functional antagonism of E2F DNA binding activity.

Conclusions:

  • E2F inactivation via peptide antagonism effectively induces apoptosis in tumor cells.
  • Targeting E2F represents a promising therapeutic avenue for cancer treatment.
  • This approach may restore growth control in cancers with deregulated E2F pathways.

More Related Videos

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...